Impact Biotech vs Nectin Therapeutics
Impact Biotech vs Nectin Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Impact Biotech is on 39/100 and Nectin Therapeutics on 50/100.
Where each one leads
Impact Biotech
- headcount: 42 against 11
- headcount growth: +16.9% against +2.9%
Nectin Therapeutics
- our overall score: 50/100 against 39/100
- domain rating: 23/100 against 20/100
- funding raised: $64.1M against $2.7M
At a glance
| Measure | Impact Biotech | Nectin Therapeutics |
|---|---|---|
| What it is | Develops and launches Padeliporfin VTP therapy for solid tumor treatment. | Biotech company developing next-generation immunotherapy agents to unlock the immune system. |
| Category | Life Sciences, Cancer, Therapeutics, Biotech | Life Sciences, Immunotherapy, Immunology, Cancer |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 1996 | 2016 |
| Headquarters | Tel Aviv, Israel | Not published |
| Status | Active | Active |
Size, funding and growth
| Measure | Impact Biotech | Nectin Therapeutics |
|---|---|---|
| Employees | 42 | 11 |
| Headcount growthLast 12 months | +16.9% | +2.9% |
| Total funding | $2.7M | $64.1M |
| Latest round | Grant | Series C |
| LinkedIn followers | 1,470 | 1,591 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Impact Biotech | Nectin Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 50/100 |
| Traction | 49/100 | 50/100 |
| Team | Not published | 30/100 |
| Search visibility | 34/100 | 30/100 |
| Quality | 45/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Impact Biotech | Nectin Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4, Segment |
Impact Biotech vs Nectin Therapeutics: common questions
Which is better, Impact Biotech or Nectin Therapeutics?
On our 0-100 score Nectin Therapeutics rates higher (50/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Impact Biotech and Nectin Therapeutics compare on the numbers?
Impact Biotech leads on headcount (42 against 11), headcount growth (+16.9% against +2.9%). Nectin Therapeutics leads on our overall score (50/100 against 39/100), domain rating (23/100 against 20/100), funding raised ($64.1M against $2.7M).
Read the full Impact Biotech review and pricing or the Nectin Therapeutics review and pricing. You can also browse other Impact Biotech alternatives we track.